MedTrace Logo

Evaluation of HEMO2Life® for Kidney Graft Preservation (OXYOP): 4 Years Follow-up

NCT05050513 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 116

Last updated 2021-09-20

No results posted yet for this study

Summary

4 years follow-up of the oxyop study.

Conditions

  • Transplant; Complication, Failure

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Yannick le Meur · University hospital Brest France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050513 on ClinicalTrials.gov